Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New mouse models for human lung infections

Sep. 2, 2019

Beijing Kawin Technology Share-Holding discloses anti-IL-4RA antibodies

Aug. 30, 2019

Neutrophils stick with dipeptidase in lung, liver

Aug. 30, 2019

New global phase IIa study evaluates tezepelumab for moderate to very severe COPD

Aug. 27, 2019

Daewoong's pulmonary fibrosis drug DWN-12088 enters global phase I trial

Aug. 26, 2019

Phase II biomarker study of oral dexpramipexole in moderate to severe eosinophilic asthma

Aug. 20, 2019

CureVac, Yale to jointly discover mRNA-based candidates for pulmonary diseases

Aug. 14, 2019

Chiesi Farmaceutici initiates phase I study of CHF-6523 in COPD

Aug. 8, 2019

Positive phase II data presented for dry powder inhaler formulation of ensifentrine

Aug. 5, 2019

Arcturus receives additional support from CF Foundation to develop mRNA therapies to treat CF

Aug. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...